Ensysce Biosciences (ENSC) Receivables (2021 - 2025)
Historic Receivables for Ensysce Biosciences (ENSC) over the last 5 years, with Q3 2025 value amounting to $8.9 million.
- Ensysce Biosciences' Receivables changed N/A to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is 8403.24% down from last year.
- As of Q3 2025, Ensysce Biosciences' Receivables stood at $8.9 million.
- Over the past 5 years, Ensysce Biosciences' Receivables peaked at $10.9 million during Q2 2022, and registered a low of $1.7 million during Q4 2024.
- For the 5-year period, Ensysce Biosciences' Receivables averaged around $6.6 million, with its median value being $8.9 million (2025).
- Per our database at Business Quant, Ensysce Biosciences' Receivables plummeted by 8403.24% in 2024 and then soared by 39924.04% in 2025.
- Over the past 5 years, Ensysce Biosciences' Receivables (Quarter) stood at $2.9 million in 2021, then soared by 279.58% to $10.9 million in 2022, then fell by 1.07% to $10.8 million in 2023, then plummeted by 84.03% to $1.7 million in 2024, then soared by 416.46% to $8.9 million in 2025.
- Its Receivables stands at $8.9 million for Q3 2025, versus $10.6 million for Q2 2025 and $9.2 million for Q1 2025.